Coronavirus India News Live Updates: India reported 37,148 cases and 587 deaths in the last 24 hours, taking the total number of coronavirus infections to 11,55,191 including 28084 casualties, 4,02,529 active cases and 7,24,578 people who have been treated and discharged so far, according to the data by Ministry of Health and Family Welfare. Globally, 14,703,293 people have been infected, 609,887 have died and 8,290,431 have recovered so far.
The Health Ministry and the Indian Council of Medical Research (ICMR) have suggested a set of short-term and medium-term actions for state governments to enhance the country’s Covid-19 testing capacity.
AIIMS Director Dr. Randeep Guleria, who is part of the core team monitoring the pandemic in India, has told The Indian Express that data from the national capital suggests that the COVID curve is flattening and Delhi “may have crossed the peak”.
Meanwhile, the Centre has written to all states and union territories warning against the use of N-95 masks with valved respirators by people, saying these do not prevent the virus from spreading out and are “detrimental” to the measures adopted for its containment.
Coming to the vaccine-related news, a coronavirus vaccine the University of Oxford is developing with AstraZeneca Plc has shown promising results in early human testing, a sign of progress in the high-stakes pursuit of a shot to defeat the pathogen. The vaccine increased levels of both protective neutralizing antibodies and immune T-cells that target the virus, according to the study organizers. The results of the study were published in the medical journal.
Double-shot Covid-19 vaccine tests raise a new pandemic challenge
After the surge in cases, Telangana’s Covid-19 recovery rate improves
After weeks of rising Covid-19 cases in Telangana, especially Hyderabad, the state’s recovery rate has now improved to 72 percent while the death rate is less than one percent, according to government data. As on July 19, 32,438 patients of the 45,076 cases in the state had recovered, while 409 had succumbed to the virus.
Meanwhile, on Monday, the first dose of the vaccine Covaxin, developed by Bharat Biotech and currently in the trials phase— was administered to two volunteers at the Nizam’s Institute of Medical Sciences (NIMS). The blood samples and swabs of at least 12 healthy volunteers had been sent last week by NIMS to ICMR-designated labs in New Delhi for testing. ICMR had cleared two volunteers for the trial.